To determine the source of elevated serum TFF3 levels associated with gastric cancer and to elucidate the mechanism underlying the persistently high serum TFF3 levels after gastric cancer resection.
Approach:
Animal Study Design: The study involved Jcl:SD rats and C57BL/6 mice, with groups receiving either control or carcinogenic treatments. Total gastrectomy was performed on specific groups, and blood samples were collected for analysis.
ELISA Analysis: Plasma levels of TFF1, TFF2, and TFF3 were measured using ELISA, with recombinant proteins expressed in E. coli for the assay.
Key Findings:
Serum TFF3 levels remain elevated even after total gastrectomy in gastric cancer patients.
TFF3 is identified as the most effective marker for gastric cancer screening compared to TFF1 and TFF2.
Interpretation:
Understanding the extra-gastric regulation of TFF3 is crucial for defining the validity and limitations of serum TFF3 as a non-invasive surrogate marker for gastric cancer risk assessment.
Limitations:
The study primarily involved animal models, which may not fully replicate human physiology.
The sample size and specific conditions of the experiments could limit the generalizability of the findings.
Conclusion:
Clarifying the mechanism of elevated serum TFF3 levels is important for understanding its role in gastric cancer.
